The papers came from many different countries such as Brazil, USA, Turkey, China, Belgium, Qatar and Colombia and as usual the editor´s comment highlights some of them.In the present issue we present a important reviews about Vesical Imaging Reporting and Data System (VI-RADS) in bladder cancer diagnosis. The paper about the group of Dr.Nicola and colleagues from USA and Brazil in page 609 shows a very complete narrative review about the topic (1). The authors shows that. the technological innovation of MR imaging has advanced the assessment of bladder cancer. MR findings can be incorporated to increase the accuracy of the traditional prediction models as the EORTC, CUETO, and EAU risk stratification. The authors conclude that the use and implication of VI-RADS will improve the communication in the diagnosis, staging and surveillance of patients with bladder cancer. The editor in chief would like to highlight the following works too:Dr. Bai and colleagues from China, presented in page 625 (2) a nice systematic review about the trifecta achievement in patients undergoing partial nephrectomy and conclude that the larger tumor size, medium and high PADUA score are associated with decreased probability of trifecta achievement.Dr. Qin and colleagues from China performed in page 637 (3) a interesting systematic review about the Comparison of mini percutaneous nephrolithotomy and standard percutaneous nephrolithotomy for renal stones >2cm and concluded that in the treatment of >2cm renal stones, mini-PCNL should be considered an effective and reliable alternative to standard-PCNL (30FR) with less blood loss, lower transfusion rate, and shorter hospitalization. However, the mini-PCNL does not show a significant advantage over the 24F standard-PCNL. On the contrary, this procedure takes a longer operation time.Dr. Terziotti and colleagues from Brazil performed in page 649 (4) an interesting retrospective study about the incontinence outcomes in women undergoing retropubic mid-urethral sling and conclude that both hand-made synthetic sling (HMS) and SafyreTM have similar satisfaction and subjective cure rates, with marked International Consultation on Incontinence Modular Questionnaire